Published in Lancet on October 05, 1968
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). Br J Pharmacol (1971) 6.11
Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J (1973) 5.65
Monitoring adverse reactions to drugs. Br Med J (1977) 4.41
Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. Q J Med (1970) 3.71
A symptom questionnaire for hypertensive patients. J Chronic Dis (1974) 3.51
Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet (1968) 3.33
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Blood-gas changes after acute myocardial infarction. Lancet (1966) 2.61
Effect of propranolol in mild hypertension. Lancet (1966) 2.57
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols. Lancet (1970) 2.48
Prostacyclin is not a circulating hormone in man. Prostaglandins (1982) 2.46
European journals, societies, and meetings. Meetings. Br Med J (1973) 2.46
Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet (1966) 2.44
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J (1980) 2.36
Clinical medicine and research in France. Br Med J (1973) 2.32
Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet (1991) 2.27
Computer-based hypertension clinic records: a co-operative study. Br Med J (1974) 2.24
Intravenously administered isoproterenol sulfate dose-response curves in man. Arch Intern Med (1972) 2.23
Drugs and the liver. Clin Pharmacol Ther (1998) 2.23
Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet (1967) 2.22
Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22
Imaging of the brain by nuclear magnetic resonance. Lancet (1981) 2.19
Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15
Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J (1976) 2.13
Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine). Clin Sci (1971) 2.11
The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J (1969) 2.06
Absorption and metabolism of nicotine from cigarettes. Br Med J (1975) 2.01
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01
I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. Br J Ophthalmol (1966) 1.99
Pharmacokinetics of indoramin in man. Br J Clin Pharmacol (1976) 1.97
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1970) 1.92
Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91
Hypertension and hyperuricaemia. Lancet (1966) 1.86
Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. J Clin Invest (1974) 1.85
Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol (1973) 1.85
Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet (1981) 1.84
Dose-dependent enzyme induction. Clin Pharmacol Ther (1973) 1.84
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol (1975) 1.79
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Clinical evaluation of indoramin, a new antihypertensive agent. Eur J Clin Pharmacol (1973) 1.78
Minoxidil in resistant hypertension. Lancet (1977) 1.77
Clinical implications of enzyme induction. Ann N Y Acad Sci (1971) 1.76
Changes in plasma -glutamyl transpeptidase activity associated with alterations in drug metabolism in man. Br Med J (1973) 1.76
The drug treatment of hypertension. Practitioner (1971) 1.75
Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet (1982) 1.73
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
Vitamin-D deficiency and primary hyperparathyroidism. Lancet (1971) 1.71
Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) (1983) 1.70
Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication. Lancet (1987) 1.70
Jaundice after Transfusion of Whole Blood or Human Plasma. Br Med J (1944) 1.69
Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol (1989) 1.68
Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet (1989) 1.66
Changes in liver blood flow during enzyme induction. Biochem Pharmacol (1971) 1.65
Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis (1986) 1.65
Initial clinical evaluation of a whole body nuclear magnetic resonance (NMR) tomograph. J Comput Assist Tomogr (1982) 1.63
Kinetics of warfarin absorption in man. Clin Pharmacol Ther (1974) 1.63
Interindividual differences in rates of drug oxidation in man. Drug Metab Dispos (1974) 1.63
An assessment of radiological criteria used in the study of spinal osteoporosis. Br J Radiol (1967) 1.62
Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet (1966) 1.61
Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man. Clin Pharmacol Ther (1974) 1.61
Clinical NMR imaging of the brain: 140 cases. AJR Am J Roentgenol (1982) 1.61
Left ventricular angiography on exercise. A new method of assessing left ventricular function in ischaemic heart disease. Br Heart J (1976) 1.60
Editorial: Pharmacokinetics--master or servant? Eur J Clin Pharmacol (1973) 1.57
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther (1975) 1.56
Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1969) 1.56
Influence on patient management of general practitioner direct access to radiological services. Br J Radiol (1987) 1.55
Cine angiography of left ventricular aneurysms. Clin Radiol (1972) 1.53
Clinical pharmacology and therapeutics in undergraduate medical education in the UK: current status. Br J Clin Pharmacol (1994) 1.53
Alveolar gas concentrations of fluorocarbons-11 and-12 in man after use of pressurized aerosols. Thorax (1974) 1.52
Another look at diagnostic pathways in children with urinary tract infection. Br Med J (Clin Res Ed) (1984) 1.51
Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation (1976) 1.50
Treating mild hypertension. Br Med J (Clin Res Ed) (1985) 1.49
The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q J Med (1982) 1.49
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J (1980) 1.49
The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol (1987) 1.49
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48
Increased pulmonary alpha-adrenergic and reduced beta-adrenergic receptors in experimental asthma. Nature (1980) 1.46
Measurement of plasma histamine in asthma. Clin Allergy (1983) 1.46
Effect of enalapril on the skin response to bradykinin in man. Br J Clin Pharmacol (1987) 1.46
Magnetic resonance imaging of spinal cord in multiple sclerosis by fluid-attenuated inversion recovery. Lancet (1993) 1.46
The effect of phenobarbitone-induction on vitamin D metabolism. Clin Sci (1972) 1.46
Central hypotensive effect of propranolol in the rabbit. Br J Pharmacol (1973) 1.44
Too many cystograms in the investigation of urinary tract infection in children? Br J Urol (1983) 1.44
Surgical treatment of emphysema. Br Med J (1966) 1.44
Postgraduate education in therapeutics: experience in Merseyside. Br Med J (1978) 1.44
The importance of central adrenergic neurones in renal hypertension in rabbits. J Physiol (1974) 1.43
Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet (1981) 1.42
Hypertension in the young. Q J Med (1967) 1.42